Related Experiment Videos
Oral terbutaline for the treatment of priapism
F E Govier1, E Jonsson, D Kramer-Levien
1Section of Urology, Virginia Mason Medical Center, Seattle, Washington.
The Journal of Urology
|April 1, 1994
Abstract:
The widespread use of penile injections in the management of erectile dysfunction has led to an increased incidence of priapism. It has been suggested that terbutaline, a beta-agonist, might be beneficial in treating priapism in this setting. We randomized 24 patients with prolonged erections to a prospective, double-blind, placebo-controlled trial. We did not find any benefit of oral terbutaline over placebo in these patients.